WORC's Guide to Genetically Modified Alfalfa
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Roundup Ready Wheat – an Overview Based on Advancements in the Risk Assessment of Genetically Engineered Crops
Roundup Ready Wheat – An Overview Based on Advancements in the Risk Assessment of Genetically Engineered Crops by Doug Gurian-Sherman, Ph.D. Center for Science in the Public Interest 1875 Connecticut Avenue, N.W., Suite 300 Washington, DC 20009-5728 Phone: (202) 332-9110 www.cspinet.org TABLE OF CONTENTS SECTION PAGE Abstract................................................................................................................................. 2 Introduction.......................................................................................................................... 3 Background on the U.S. Regulatory System for GE Crops ............................................. 3 Characterization of the Transgene and Transgenic Protein............................................ 4 Human Safety....................................................................................................................... 6 Allergenicity ...................................................................................................................... 7 Unintended Adverse Effects.............................................................................................. 9 Environmental Issues ........................................................................................................ 11 Resistance Management ................................................................................................. 12 Gene Transfer.............................................................................................................. -
VIA CERTIFIED MAIL RETURN RECEIPT REQUESTED September 26, 2013 Secretary Vilsack U.S. Department of Agriculture (USDA) Animal He
VIA CERTIFIED MAIL RETURN RECEIPT REQUESTED September 26, 2013 Secretary Vilsack U.S. Department of Agriculture (USDA) Animal Health and Plant Inspection Service (APHIS) 1400 Independence Ave., S.W. Washington, DC 20250 Petition for Agency Action, Rulemaking, Investigation, and Otherwise Collateral Relief on Recent Genetically Engineered Alfalfa Contamination Introduction Pursuant to the Right to Petition the Government Clause of the United States Constitution,1 the Administrative Procedure Act (APA),2 and United States Department of Agriculture (USDA)’s implementing regulations,3 petitioner Center for Food Safety (CFS) respectfully submits this petition for agency action, rulemaking, and collateral relief on behalf of its over 350,000 farmer and consumer members, including alfalfa farmers Joseph and Michelle Peila. CFS requests that the Department retract its September 17, 2013 decision and take all regulatory action needed to remedy the current genetically engineered (GE) alfalfa contamination because its original decision was based on erroneous factual information—that the transgenic contamination occurred after GE Roundup Ready alfalfa was approved for commercial sale. In fact, records indicate that the seed used for the rejected contaminated alfalfa itself tested positive for Roundup Ready contamination, and this seed was purchased in 2010, before the deregulation of Roundup Ready alfalfa. CFS is a nationwide public interest non-profit membership organization with offices in Washington, D.C., San Francisco, CA, and Portland, OR. Since the organization’s founding in 1997, CFS has sought to ameliorate the adverse impacts of industrial farming and food production systems on human health, animal welfare, and the environment. CFS also supports and promotes sustainable forms of agriculture, including organic systems. -
Plant Molecular Farming: a Viable Platform for Recombinant Biopharmaceutical Production
plants Review Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production Balamurugan Shanmugaraj 1,2, Christine Joy I. Bulaon 2 and Waranyoo Phoolcharoen 1,2,* 1 Research Unit for Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok 10330, Thailand; [email protected] 2 Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences Chulalongkorn University, Bangkok 10330, Thailand; [email protected] * Correspondence: [email protected]; Tel.: +66-2-218-8359; Fax: +66-2-218-8357 Received: 1 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing steadily, which is attracting global attention for the development of new recombinant protein production technologies and the engineering of conventional established expression systems based on bacteria or mammalian cell cultures. Since the advancements of plant genetic engineering in the 1980s, plants have been used for the production of economically valuable, biologically active non-native proteins or biopharmaceuticals, the concept termed as plant molecular farming (PMF). PMF is considered as a cost-effective technology that has grown and advanced tremendously over the past two decades. The development and improvement of the transient expression system has significantly reduced the protein production timeline and greatly improved the protein yield in plants. The major factors that drive the plant-based platform towards potential competitors for the conventional expression system are cost-effectiveness, scalability, flexibility, versatility, and robustness of the system. Many biopharmaceuticals including recombinant vaccine antigens, monoclonal antibodies, and other commercially viable proteins are produced in plants, some of which are in the pre-clinical and clinical pipeline. -
US EPA, Pesticide Product Label, WIDESTRIKE 3 INSECT
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION October 18, 2016 Stephanie L. Burton US Regulatory Manager Dow AgroSciences LLC 9330 Zionsville Road Indianapolis, IN 46268-1054 Subject: PRIA (Pesticide Registration Improvement Act) Amendment – to update the terms of registration related to gene flow and revise the product label. Product Name: WideStrike® 3 Insect Resistant Cotton EPA Registration Number: 68467-19 Application Date: June 23, 2016 OPP Decision Number: 518794 Dear Ms. Burton: The amendment referred to above, submitted in connection with registration under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended, are acceptable provided you comply with the revised terms of registration as set forth below: 1. Submit/cite all data required for registration of your product under FIFRA § 3(c)(5) when the Agency requires all registrants of similar products to submit such data. 2. Gene Flow The following information regarding commercial production must be included in the grower guide for WideStrike® 3 Insect Resistant Cotton: a) No planting of WideStrike® 3 Insect Resistant Cotton is permitted south of Route 60 (near Tampa) in Florida. b) Commercial culture of WideStrike® 3 Insect Resistant Cotton is prohibited in Hawaii, Puerto Rico, and the US Virgin Islands. The following information regarding test plots and seed production must appear in contracts or on bags of WideStrike® 3 Insect Resistant Cotton intended for the following purposes: Page 2 of 10 EPA Reg. No. 68467-19 OPP Decision No. 518794 a) Test plots or breeding nurseries, regardless of the plot size, established in Hawaii must not be planted within 3 miles of Gossypium tomentosum. -
Position Statement on Genetically Engineered Food
Position Statement on Genetically Engineered Food ealth Care Without Harm opposes the produc- Human Health Concerns tion and marketing of genetically engineered Few long-term studies have been conducted to assure that H(GE) foods. These foods are not adequately production and consumption of GE foods will carry no assessed for their credible adverse effects on human or adverse long-term health impacts. A 2003 peer-reviewed animal health, or on the environment in which they are literature search found just ten published studies specifi- produced. Also of concern is the threat posed by genetic cally designed to assess the potential for health effects engineering to environmentally sustainable food produc- from GE foods or feed.4 For hospitals, patient health is tion and the threat to the economic livelihood of farmers of particular concern, since some patients may be more pursing sustainable food production. vulnerable to possible problems from GE foods than the We therefore encourage health care providers to purchase general public. For example, full digestion of proteins de- non-GE foods to the extent possible and to source from creases the likelihood they will survive to produce harm suppliers that demonstrate a strong commitment to al- (via direct toxicity or allergenicity), whereas digestive ternatives to GE food, and that support local farmers and function is sometimes compromised in hospital patients. sustainable practices. The immune system in such patients may also be compro- mised, making them more generally susceptible to harm. Background Allergies: Genetic engineering moves proteins novel For about a decade,1 companies have introduced geneti- to the human diet into the food supply. -
Harness Xtra Herbicide, EPA Registration REPACKAGING LIMITATIONS
ATTENTION: This specimen label is provided for general information only. • This pesticide product may not yet be available or approved for sale or use in your area. • It is your responsibility to follow all Federal, state and local laws and regulations regarding the use of pesticides. • Before using any pesticide, be sure the intended use is approved in your state or locality. • Your state or locality may require additional precautions and instructions for use of this product that are not included here. • Monsanto does not guarantee the completeness or accuracy of this specimen label. The information found in this label may differ from the information found on the product label. You must have the EPA approved labeling with you at the time of use and must read and follow all label directions. • You should not base any use of a similar product on the precautions, instructions for use or other information you find here. • Always follow the precautions and instructions for use on the label of the pesticide you are using. 36021K6-29 3.0 PRECAUTIONARY STATEMENTS RESTRICTED USE PESTICIDE due to ground and surface water concerns. For retail sale to and use only by .1 Hazards to Humans and Domestic Animals Certified Applicators, or persons under their direct supervision and only for those 3 uses covered by the Certified Applicator’s certification. Keep out of reach of children. CAUTION! HARMFUL IF SWALLOWED. HARMFUL IF INHALED. CAUSES MODERATE EYE IRRITATION. ® MAY CAUSE ALLERGIC SKIN REACTION. Avoid contact with skin, eyes, or clothing. Avoid breathing spray mist. Prolonged or frequently repeated skin contact may cause allergic reactions in some individuals. -
Monsanto Company in Microsoft Word Format Together with a Copy of the Transmittal Letter That Accompanies the Filing of Two Paper Copies of the Submission
From: Letzler, Kenneth [mailto:[email protected]] Sent: Thursday, December 31, 2009 1:03 PM To: ATR-Agricultural Workshops Subject: Comment Attached please find a comment submitted on behalf of Monsanto Company in Microsoft Word format together with a copy of the transmittal letter that accompanies the filing of two paper copies of the submission. _____________________________ U.S. Treasury Circular 230 Notice Any U.S. federal tax advice included in this communication (including any attachments) was not intended or written to be used, and cannot be used, for the purpose of (i) avoiding U.S. federal tax-related penalties or (ii) promoting, marketing or recommending to another party any tax-related matter addressed herein. _____________________________ This communication may contain information that is legally privileged, confidential or exempt from disclosure. If you are not the intended recipient, please note that any dissemination, distribution, or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer. ---------------------------------------------------------------------- For more information about Arnold & Porter LLP, click here: http://www.arnoldporter.com Competition and Innovation in American Agriculture A Response to the American Antitrust Institute’s “Transgenic Seed Platforms: Competition Between a Rock and a Hard Place?” Submitted on Behalf of Monsanto Company In Response to the Request for Comments by the United States Department of Agriculture and United States Department of Justice, Antitrust Division, in Connection with Their Hearings on “Agriculture and Antitrust Enforcement Issues in Our 21st Century Economy” Vandy Howell, Ph.D. -
Dow Agrosciences
Dow AgroSciences LLC (Dow AgroSciences) markets crop protection Dow AgroSciences products and seeds for a broad spectrum of crops, including maize, soybean, cotton and forage. The company began in the 1950s as the agricultural unit of The Dow Chemical Company. As a joint venture Corporate Data of The Dow Chemical Company and Eli Lilly & Co., it was known as Headquarters: Indianapolis, Indiana, USA DowElanco from 1989 onwards. In 1997, The Dow Chemical Company Ownership type: Listed Group revenue (2014): USD 729,000,0000 acquired 100% ownership.* Global Index – Commitment Performance Transparency Innovation Field Crop Seed Companies 1.27 1.46 2.05 0.25 Dow AgroSciences ranks in the lower 5 range of the Global Index of Field Crop Seed Companies. It has clear rank out of 7 approaches to Public Policy & Stakeholder A Governance & 1.13 score 1.38 Engagement and existing breeding Strategy B Public Policy & 2.68 programs for resistance to pests and Stakeholder Engagement diseases, abiotic stress tolerance and C Genetic Resources & 1.09 Intellectual Property yield, although it is not clear to what extent these programs D Research & 1.31 specifically target the development of varieties suitable for Development E Marketing & 1.11 Index countries and smallholder farmers. Seed sales were Sales found only in Latin American Index countries. Given the F Capacity 2.08 indications of research and capacity-building activities rel- Building G Local Seed Sector 0.91 evant for improved access to seeds for smallholder farmers in Advancement other regions, the company is encouraged to develop its seed 0 1 2 3 4 5 business serving smallholder farmers on a more global scale. -
SUMMARY Sign Offv7
Syngenta Event GA21 Page 1 of 29 PART II: SUMMARY Application for import and use of genetically modified herbicide tolerant maize Event GA21 under Regulation (EC) No 1829/2003 PART II: SUMMARY Syngenta Event GA21 Page 2 of 29 PART II: SUMMARY A . GENERAL INFORMATION 1. Details of application a) Member State of application UK b) Application number Not available at the time of submission c) Name of the product (commercial and other names) Maize Event GA21 In the USA, GA21 is marketed under the product name Agrisure GT Advantage (http://www.nk-us.com/infosilo/seedguide/agrisure.asp) d) Date of acknowledgement of valid application Not available at the time of submission Syngenta Event GA21 Page 3 of 29 PART II: SUMMARY 2. Applicant a) Name of applicant Syngenta Seeds S.A.S on behalf of Syngenta Crop Protection AG, Basel b) Address of applicant Syngenta Seeds S.A.S. 12, chemin de l'Hobit BP 27 F-31790 Saint-Sauveur On behalf of Syngenta Crop Protection AG, Basel Switzerland and all affiliated companies Schwarzwaldallee 215 CH 4058 Basle Switzerland c) Name and address of the person established in the Community who is responsible for the placing in the market, whether it be the manufacturer, the importer or the distributor, if different from the applicant (Commission Decision 2004/204/EC Art 3(a)(ii)) Event GA21 maize will be imported and used as any other maize in the EU by operators currently involved in these processes. 3. Scope of the application x GM plants for food use x Food containing or consisting of GM plants xFood produced from GM plants or containing ingredients produced from GM plants xGM plants for feed use x Feed containing or consisting of GM plants x Feed produced from GM plants x Import and processing (Part C of Directive 2001/18/EC) o Seeds and plant propagating material for cultivation in Europe (Part C of Directive 2001/18/EC) Syngenta Event GA21 Page 4 of 29 PART II: SUMMARY 4. -
Agricultural Biotechnology: Benefits of Transgenic Soybeans
AGRICULTURAL BIOTECHNOLOGY: BENEFITS OF TRANSGENIC SOYBEANS Leonard P. Gianessi Janet E. Carpenter April 2000 National Center for Food and Agricultural Policy 1616 P Street, NW, First Floor Washington, DC 20036 Tel: 202-328-5048 Fax: 202-328-5133 [email protected] Preparation of this report was supported financially with a grant from the Rockefeller Foundation TABLE OF CONTENTS 1. Introduction 2. U.S. Soybean Production 3. Soybean Products 4. Soybean Physiology 5. Soybeans – Agronomic Factors 6. Soybean Genetic Improvements A. Introduction B. Reproductive Process C. Artificial Cross Breeding D. Mutation Breeding E. Transgenic Plants 7. Weed Competition – Soybeans 8. Weed Control in Soybeans: 1940’s – 1950’s 9. Herbicides – An Overview 10. Herbicide Use in Soybeans: 1960’s – 1995 A. Introduction B. Historical Overview 1. The Early 1960’s 2. Soil Applied Herbicides 3. Postemergence Herbicides 4. Sulfonylurea/Imidazolinone Herbicides 5. Burndown Herbicides C. Summary of Usage: 1995 11. Transgenic Herbicide Tolerant Soybeans A. Glyphosate – An Overview B. Performance of Roundup Ready Soybeans C. Herbicide Ratings D. Adoption Impacts: 1995 – 1998 1. Herbicide Costs 2. Soybean Yields 3. Returns 4. Other Aggregate Studies 5. Herbicide Treatments 6. Herbicide Use Amounts 7. Other Impacts 12. Summary and Conclusions 13. References Appendix 1: Soybean Processing – A Description 1. Introduction Soybeans and other crops have been improved genetically for many decades through traditional crop breeding – a technique that requires that species be sexually compatible. With the development of biotechnology methods, scientists have the ability to transfer single genes from one living organism into another, regardless of species or sexual compatibility. Varieties that are developed through the transfer of genes between species that are not sexually compatible are referred to as “transgenic.” Transgenic soybean plants have been developed with a gene from a soil bacteria that allows the use of an herbicide that would normally kill soybeans. -
The Era of Corporate Consolidation and the End of Competition Bayer-Monsanto, Dow-Dupont, and Chemchina-Syngenta
Research Brief October 2018 The Era of Corporate Consolidation and the End of Competition Bayer-Monsanto, Dow-DuPont, and ChemChina-Syngenta DISRUPT ECOSYSTEM ACCLERATE MONOPOLY THE EFFECTS OF CORPORATE CONSOLIDATION UNDERMINE FOOD SECURITY HARM SMALL PRODUCERS HAASINSTITUTE.BERKELEY.EDU This publication is published by the Haas Institute for a Fair and Inclusive Society at UC Berkeley This research brief is part of the Haas Institute's Shahidi Project from the Global Justice Program. The Shahidi Project (Shahidi is a Swahili word meaning “witness”) intends to demystify the power structures and capacities of transnational food and agricultural corporations within our food system. To that end, researchers have developed a robust database focusing on ten of the largest food and agricultural corporations in the world. See more at haasinstitute.berkeley.edu/shahidi. About the Authors Copyeditor Support Elsadig Elsheikh is the director Marc Abizeid Special thanks to the Food of the Global Justice program and Farm Communications at the Haas Institute for a Infographics Fund, which provided the seed Fair and Inclusive Society at Samir Gambhir funding for the Shahidi project. the University of California- Berkeley, where he oversees Report Citation Contact the program’s projects and Elsadig Elsheikh and Hossein 460 Stephens Hall research on corporate power, Ayazi. “The Era of Corporate Berkeley, CA 94720-2330 food system, forced migration, Consolidation and The End of Tel 510-642-3326 human rights, Islamophobia, Competition: Bayer-Monsanto, haasinstitute.berkeley.edu structural marginality and Dow-DuPont, and ChemChina- inclusion, and trade and Syngenta.” Haas Institute for development. a Fair and Inclusive Society at the University of California, Hossein Ayazi, PhD, is a Berkeley, CA. -
Media Release Syngenta Group: Growth of Sustainability- Enabling
Media Release Syngenta Group: Growth of sustainability- enabling products and services drives record H1 2021 Syngenta Group’s focus on helping farmers adapt to climate change and be part of the solution is creating growth opportunities • H1 Group sales at $14.4 billion (+$2.8 billion), +24 percent year-on-year • Q2 Group sales of $7.4 billion (+$1.6 billion), +28 percent year-on-year • H1 EBITDA at $2.7 billion, +22 percent year-on-year • Q2 EBITDA at $1.2 billion, +25 percent year-on-year • First half performance shows strong demand from farmers for sustainable products and services • Growth driven by Group’s innovation in seeds and crop protection products that enable regenerative agricultural practices • The Modern Agriculture Platform (MAP), which provides farmers with access to market-leading products and services, more than tripled sales year-on-year • Syngenta biologicals sales, including Valagro, grew 27 percent in H1, strengthening the Group’s leading position in this high growth segment 26 August 2021, Basel / Switzerland Syngenta Group today reported strong financial results for the second quarter and first half ended June 30, 2021. Group sales in second quarter were $7.4 billion, up 28 percent versus Q2 2020 (+25 percent at CER). EBITDA increased in the second quarter 25 percent (+38 percent at CER) to $1.2 billion. Group sales for the first half of 2021 were $14.4 billion, up 24 percent year-on-year (+18 percent at CER). EBITDA for the first half of the year was $2.7 billion, 22 percent higher year-on-year (+25 percent at CER).